# Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-tofacitinib-for-the-treatment-of-moderate-to-severe-active/

## Facts

| Field | Value |
| --- | --- |
| Author Names | K. Vellopoulou,Garyfallia Stefanou,C. Tzanetakos,Nantia Boubouchairopoulou,M. Nakou,George Gourzoulidis,Georgia Kourlaba |
| Citations | 10 |
| DOI | 10.1097/meg.0000000000001916 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3089240968 |
| PMID | 32976189 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Garyfallia Stefanou](https://scholariq.org/researchers/garyfallia-stefanou/)

## Paper journal

- [European Journal of Gastroenterology & Hepatology](https://scholariq.org/journals/european-journal-of-gastroenterology-and-hepatology/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.